| 2715 |
1547: Mitochondrial Injury |
1825: Increase, Cell death |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 3049 |
1547: Mitochondrial Injury |
1812: Increase, Cyt c release |
Sep 14, 2023 |
Sep 14, 2023 |
1 AOP
|
| 603 |
598: modulation, sodium channel |
599: prolonged, Depolarization of neuronal membrane |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 802 |
801: modulation, Unknown |
802: Increased, HIF-1 alpha transcription |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2448 |
1912: Motile Cilia Number/Length, Decreased |
1908: CBF, Decreased |
Jul 23, 2021 |
Sep 28, 2021 |
1 AOP
|
| 1563 |
1425: Mu Opioid Receptor Agonism |
1426: Release of G Proteins |
Jun 8, 2017 |
Jun 8, 2017 |
2 AOPs
|
| 2443 |
1909: MCC, Decreased |
1250: Decreased lung function |
Jul 19, 2021 |
Mar 24, 2023 |
3 AOPs
|
| 2445 |
1910: Mucus Viscosity, Increased |
1908: CBF, Decreased |
Jul 19, 2021 |
Aug 2, 2021 |
None
|
| 2446 |
1910: Mucus Viscosity, Increased |
1909: MCC, Decreased |
Jul 19, 2021 |
Aug 2, 2021 |
None
|
| 757 |
764: N/A, Ataxia, paralysis, or hyperactivity |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 88 |
75: N/A, Covalent binding to protein, possibly lysine residue |
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways |
Nov 29, 2016 |
Sep 24, 2020 |
None
|
| 1700 |
75: N/A, Covalent binding to protein, possibly lysine residue |
398: Activation, Dendritic Cells |
Dec 7, 2017 |
Sep 24, 2020 |
None
|
| 136 |
119: N/A, Gap |
49: Reduction, Ca and HCO3 transport to shell gland |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 996 |
139: N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects |
854: Alterations, Cellular proliferation / hyperplasia |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 593 |
590: N/A, hypoxia |
591: Increased, amputations |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3307 |
590: N/A, hypoxia |
1376: Increase, angiogenesis |
Jul 18, 2024 |
Jul 18, 2024 |
None
|
| 3370 |
590: N/A, hypoxia |
885: Increase, Cancer |
Oct 25, 2024 |
Oct 25, 2024 |
1 AOP
|
| 168 |
158: N/A, Interferences with SH-/selen-proteins |
130: Depletion, GSH |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2889 |
345: N/A, Liver Steatosis |
55: Cell injury/death |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 182 |
173: N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number |
321: N/A, Cyanosis occurs |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 207 |
352: N/A, Neurodegeneration |
188: Neuroinflammation |
Nov 29, 2016 |
Jun 13, 2018 |
2 AOPs
|
| 368 |
352: N/A, Neurodegeneration |
386: Neuronal network function, Decreased |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 647 |
352: N/A, Neurodegeneration |
618: Decreased, Neuronal network function in adult brain |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 1069 |
352: N/A, Neurodegeneration |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Apr 11, 2024 |
2 AOPs
|
| 2287 |
352: N/A, Neurodegeneration |
1841: Encephalitis |
Feb 23, 2021 |
Feb 23, 2021 |
2 AOPs
|